External control arms and debunking real-world data myths
pharmaphorum
AUGUST 31, 2021
Beyond the FDA, other institutions have documented what industry standards should look like in assessing RWD in a regulatory context. This can require new processes, technologies and an organisation mind shift.”. Furthermore, ECAs are well-documented in the post-approval setting.
Let's personalize your content